A new mechanism that slows down and may even prevent the natural ageing of immune cells – one of the nine hallmarks of ageing – has been identified by an international team led by UCL scientists.
Published in Nature Cell Biology, researchers say the discovery in-vitro (cells) and validated in mice was ‘unexpected’ and believe harnessing the mechanism could extend the life of the immune system, allowing people to live healthier and longer, and would also have clinical utility for diseases such as cancer and dementia.
Explaining the study, lead author, Dr Alessio Lanna, Honorary Professor at UCL Division of Medicine, said: “Immune cells are on constant high-alert, always ready to fight pathogens. To be effective they also must persist for decades in the body - but the strategies employed to execute this life-long protection are largely unknown.
“In this research, we sought to find out what mechanisms exist to confer longevity to immune system cells, known as T cells, at the initiation of the immune response against an antigen - a foreign substance recognised by the immune-surveillance mechanisms of defence of the body.”
Why the immune system ages
Each of the chromosomes, present in all cells, contains a protective cap called a telomere; a specific DNA sequence that is repeated thousands of times. The sequence has two purposes: firstly, it protects the coding regions of the chromosomes and prevents them from being damaged, and secondly, it acts as an ageing clock that controls the number of replications (also known as divisions) a cell can make.
In T cells (a type of white blood or immune cell), along with most cells, the telomeres become shorter and shorter (telomere attrition) with each subsequent cell division. Once telomeres reach a critically short length, the cell ceases to divide and enters senescence – the process of being disposed by the immune system, or persist in an altered, dysfunctional state.
With the immune system no longer functioning effectively, this leads to the onset of chronic infections, cancerous disease and death. Telomere attrition has been described as one of the ‘hallmarks of ageing’*.
Study findings
In the study, in vitro, researchers initiated an immune response of T-lymphocytes against a microbe (foreign infection). Unexpectedly, they observed a telomere transfer reaction between two types of white blood cells, in ‘extracellular vesicles’ (small particles that facilitate intercellular communication). An antigen presenting cell (APC), consisting either of B cells, dendritic cells or macrophages, functioned as a ‘telomere donor’, to the T lymphocyte – the telomere recipient cell. Upon transfer of the telomeres, the recipient T cell became long-lived and possessed memory and stem cell attributes, enabling the T cell to protect a host against a lethal infection in the long term.
The telomere transfer reaction extended certain telomeres about 30 times more than extension exerted by telomerase. Telomerase is the single DNA synthesising enzyme that is devoted to telomere maintenance in stem cells, cells of the immune systems and found in fetal tissue, reproductive cells and sperm. However, it does not provide this function in other cells, leading to telomere attrition. Even in immune cells where the enzyme is naturally active, continuous immune reactions cause progressive telomerase inactivation leading to telomere shortening, when cells stop dividing, and replicative senescence occurs.
Professor Lanna added: “The telomere transfer reaction between immune cells adds to the Nobel-prize winning discovery of telomerase and shows that cells are capable of exchanging telomeres as a way to regulate chromosome length before telomerase action begins. It is possible that ageing may be slowed down or cured simply by transferring telomeres.”
Utilising the new mechanism
On discovering the new ‘anti-ageing’ mechanism, the same research team established that telomere extracellular vesicles can be purified from the blood, and, when added to T cells, present anti-ageing activities in immune systems from both humans and mice.
The researchers discovered (in human cells and mice) that the purified extracellular vesicle preparations may be administered alone or in combination with a vaccine and this extended durative immune protections that, in principle, may avoid need for revaccination.
Alternatively, the ‘telomere donor’ transfer reaction can be boosted directly in cells. While much more research is needed, the scientists say this illustrates the possibilities of new forms of prophylactic (preventative) therapies of immune senescence and age.
